(HSAI) Hesai Sponsored - Overview
Stock: LiDAR, Gas Detection, Validation Services, Engineering Products
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 82.8% |
| Relative Tail Risk | -12.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 65.73 |
| Character TTM | |
|---|---|
| Beta | 1.504 |
| Beta Downside | 1.630 |
| Drawdowns 3y | |
|---|---|
| Max DD | 84.17% |
| CAGR/Max DD | 0.06 |
Description: HSAI Hesai Sponsored January 12, 2026
Hesai Group (NASDAQ:HSAI) manufactures 3-D LiDAR sensors for autonomous and advanced driver-assistance systems (ADAS) across passenger cars, commercial fleets, and robotics (e.g., last-mile delivery, street-sweeping). The company, founded in 2014 and based in Shanghai, sells its products globally-including in China, Europe, and North America-through a mix of hardware sales, gas-detection devices, validation services, and engineering solutions.
Key industry drivers: (1) The global LiDAR market is projected to grow at a CAGR of ~23% through 2030, propelled by stricter autonomous-vehicle regulations and falling sensor costs; (2) Automotive OEMs are increasingly allocating capital to ADAS and Level-3/4 autonomy, raising demand for high-resolution, solid-state LiDAR units; (3) Supply-chain diversification pressures are encouraging U.S. and European OEMs to source from non-Chinese manufacturers, which could benefit Hesai’s international subsidiaries.
Recent performance metrics (as of FY 2023): revenue of ¥1.9 billion (~$270 million), a 38% YoY increase driven by a 45% rise in LiDAR unit shipments, and an operating margin of 12% after a prior-year loss, reflecting improved cost-structure from volume scaling. The company’s gross margin has stabilized around 55% after transitioning from prototype to volume production.
For a deeper quantitative assessment, the ValueRay platform provides a granular, data-driven view of Hesai’s valuation drivers and comparable peers.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 429.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 6.11 > 1.0 |
| NWC/Revenue: 286.5% < 20% (prev 149.7%; Δ 136.8% < -1%) |
| CFO/TA -0.00 > 3% & CFO -35.4m > Net Income 429.7m |
| Net Debt (-1.73b) to EBITDA (533.7m): -3.24 < 3 |
| Current Ratio: 5.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.5m) vs 12m ago 10.48% < -2% |
| Gross Margin: 41.34% > 18% (prev 0.44%; Δ 4091 % > 0.5%) |
| Asset Turnover: 33.36% > 50% (prev 34.52%; Δ -1.17% > 0%) |
| Interest Coverage Ratio: 26.03 > 6 (EBITDA TTM 533.7m / Interest Expense TTM 15.7m) |
Altman Z'' 2.58
| A: 0.72 (Total Current Assets 9.53b - Total Current Liabilities 1.66b) / Total Assets 10.91b |
| B: -0.29 (Retained Earnings -3.13b / Total Assets 10.91b) |
| C: 0.05 (EBIT TTM 407.5m / Avg Total Assets 8.23b) |
| D: -1.47 (Book Value of Equity -3.06b / Total Liabilities 2.07b) |
| Altman-Z'' Score: 2.58 = A |
Beneish M -2.95
| DSRI: 0.97 (Receivables 1.23b/884.0m, Revenue 2.75b/1.92b) |
| GMI: 1.05 (GM 41.34% / 43.52%) |
| AQI: 0.49 (AQ_t 0.02 / AQ_t-1 0.04) |
| SGI: 1.43 (Revenue 2.75b / 1.92b) |
| TATA: 0.04 (NI 429.7m - CFO -35.4m) / TA 10.91b) |
| Beneish M-Score: -2.95 (Cap -4..+1) = A |
What is the price of HSAI shares?
Over the past week, the price has changed by +8.92%, over one month by -2.95%, over three months by +17.59% and over the past year by +54.67%.
Is HSAI a buy, sell or hold?
- StrongBuy: 10
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HSAI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.9 | 22.6% |
| Analysts Target Price | 31.9 | 22.6% |
| ValueRay Target Price | 28.2 | 8.4% |
HSAI Fundamental Data Overview February 04, 2026
P/E Trailing = 51.2
P/E Forward = 30.8642
P/S = 1.3461
P/B = 2.9522
Revenue TTM = 2.75b CNY
EBIT TTM = 407.5m CNY
EBITDA TTM = 533.7m CNY
Long Term Debt = 315.4m CNY (from longTermDebt, last quarter)
Short Term Debt = 448.2m CNY (from shortTermDebt, last quarter)
Debt = 835.3m CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.73b CNY (from netDebt column, last quarter)
Enterprise Value = 19.14b CNY (25.67b + Debt 835.3m - CCE 7.36b)
Interest Coverage Ratio = 26.03 (Ebit TTM 407.5m / Interest Expense TTM 15.7m)
EV/FCF = -540.5x (Enterprise Value 19.14b / FCF TTM -35.4m)
FCF Yield = -0.19% (FCF TTM -35.4m / Enterprise Value 19.14b)
FCF Margin = -1.29% (FCF TTM -35.4m / Revenue TTM 2.75b)
Net Margin = 15.64% (Net Income TTM 429.7m / Revenue TTM 2.75b)
Gross Margin = 41.34% ((Revenue TTM 2.75b - Cost of Revenue TTM 1.61b) / Revenue TTM)
Gross Margin QoQ = 42.10% (prev 42.54%)
Tobins Q-Ratio = 1.75 (Enterprise Value 19.14b / Total Assets 10.91b)
Interest Expense / Debt = 0.05% (Interest Expense 451.8k / Debt 835.3m)
Taxrate = 9.69% (27.5m / 283.7m)
NOPAT = 368.0m (EBIT 407.5m * (1 - 9.69%))
Current Ratio = 5.75 (Total Current Assets 9.53b / Total Current Liabilities 1.66b)
Debt / Equity = 0.09 (Debt 835.3m / totalStockholderEquity, last quarter 8.84b)
Debt / EBITDA = -3.24 (Net Debt -1.73b / EBITDA 533.7m)
Debt / FCF = 48.80 (negative FCF - burning cash) (Net Debt -1.73b / FCF TTM -35.4m)
Total Stockholder Equity = 5.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.22% (Net Income 429.7m / Total Assets 10.91b)
RoE = 8.03% (Net Income TTM 429.7m / Total Stockholder Equity 5.35b)
RoCE = 7.19% (EBIT 407.5m / Capital Employed (Equity 5.35b + L.T.Debt 315.4m))
RoIC = 6.02% (NOPAT 368.0m / Invested Capital 6.11b)
WACC = 11.10% (E(25.67b)/V(26.50b) * Re(11.46%) + D(835.3m)/V(26.50b) * Rd(0.05%) * (1-Tc(0.10)))
Discount Rate = 11.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.51%
Fair Price DCF = unknown (Cash Flow -35.4m)
EPS Correlation: 74.44 | EPS CAGR: 376.6% | SUE: 4.0 | # QB: 1
Revenue Correlation: 89.17 | Revenue CAGR: 34.56% | SUE: -0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=4.99 | Chg30d=-0.099 | Revisions Net=+0 | Growth EPS=+52.9% | Growth Revenue=+43.2%